Rochester, Minn.-based Mayo Clinic has expanded its partnership with TripleBlind, a company that deidentifies patient data, to allow health systems and developers to collaborate on digital health solutions.
The health system's digital transformation arm, Mayo Clinic Platform, plans to use TripleBlind's software to analyze patient data without seeing, sharing or storing it and test artificial intelligence models with Mayo's Validate program while preserving intellectual property rights.
"Mayo Clinic Platform's vision is to create a healthier world where personalized, predictive and innovative care may be accessible to all," said Steve Bethke, vice president of Mayo Clinic Platform's product portfolio, in a Jan. 31 TripleBlind news release. "We're excited to collaborate with TripleBlind to enable solution developers to Validate their models, driving data-driven and scalable innovation in a secure environment."
Mayo began investing in TripleBlind and using its application programming interface for digital health research in 2021.